ϸ°ûÉúÎïѧ£º }z$_=
v
Ò»¡¢ Ãû´Ê½âÊÍ£º 8!T6N2O6d
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© Y5Ub[o
2£® PCR£¨96£© r/32pY
3£® ·ºËØ£¨ubquitin£©£¨96£© )0Lno|l
4£® °é·Ö×Ó£¨chapron£©£¨96£© V\ 7O)g
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£©
Y@+e)p{
6£® DG£IP3£¨96£© KqE5{ q
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© :JEzfI1
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© BM@:=>ypQ
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© -S ASn
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© RJz$$,RU
11£® Transformation£¨92£© yd-r7iq
12£® TransfectionתȾ£¨92£© O7MFKAaD
13£® TranscytosisתÒÆ×÷Óã¨92£© y7s:Buyc
14£® Transductionתµ¼£¨92£© TxN'[G
15£® Transdetermination£¨92£© ?0U.1N
16£® Transdifferentiation£¨92£© NJVAvq2E.
17£® Transgenic animalת»ùÒò¶¯Î92£© h{R>L s
18£® Rb£1£¨92£© ?_!} lg
19£® P53£¨92¡¢91£© >A+0"5+_p
20£® C£jun£¨92£© tY1M7B^~
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© Gs2|#*6
22£® °ûÄÚÌ壨99£© s Y^#I
23£® Cyclin dependent kinase inhibitor(CDKI)(99) OF4iGFw
24£® G£protein£¨91£© ZW6ZO[`6
25£® Restriction point£¨91£©
OMi_')J
26£® Antipost£¨91£© W!R}eLf@
27£® Capping£¨91£© UX?EOrfJ
28£® TATAbox£¨91£© D9cpw0{nc
29£® cDNA library£¨90£© .%.bIT
30£® Aritotic apparatus£¨90£© l;N?*2zm[
31£® ¿çĤÐźŠtransmembrane signal£¨90£© N,iYUM?
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© rW.o_z03^
33£® Nuclear lamina£¨90£© +zU[rhMk'
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© }67lL~L
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© l(o#N'!j4
36£® ϸ°û·Ö»¯£¨00£© tSP)'N<
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© Qx
B0I/
{
38£® ¿Ë¡£¨00£© )}
I>"n
39£® »ùÒò×飨00£© q0Hor
40£® Caspase£¨00£© D*Cn
!v$
41£® ת¼Òò×Ó£¨00£© <B
}4}-}
42£® ÅßÌ¥¸Éϸ°û£¨01£© X^?M4
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© dB{VY+!
44£® DNAоƬ£¨01£© S? -6hGA
j
¶þ¡¢ ÎÊ´ðÌ⣺ W^es"\
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© zNZ"PYh<u
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æ书ÄÜ£¨95£© *J ]2"~_.
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© ?)8OC(B8q
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© s+EJXoxw
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© MJ=(rp=YU9
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© Sk~( t
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© )A@i2I
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© i`FskEoijq
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© 0R#T 3K}
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿Øϸ°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© cZ<@1I5QK
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷Íƶ¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© 9r5<A!1#L
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© f
_
O
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© 9d\B*OU
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© {JJq/[j
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹Øϵ£¨95£© /3(|P
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© X;~3 U
9
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æ书ÄÜ£¨93£© rJ@yOed["b
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© uT#MVv~ .
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© <9BM%
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æ䶨λ¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© /]_a\x5Ss
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäÄ¿Ç°ËùÖªµÄ¹¦ÄÜ£¨01£©
x]6wiV
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖصãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© ug|'}\LY
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© #dd-rooQuD
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© B!;qz[]I
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© cAL*Md8+
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆڵĵ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© YFGQPg
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹Øϵ£¨91£© ,X&(BQj h
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© XDot3)2`
29£® ÊÔÊöºáÎƼ¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© >h[ {_+
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æ书ÄÜ£¨95£© SEL7,8 Hm
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© miq"3
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© ;&A%"8o
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© "F$0NYb]I
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© +Vf39}8
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©